PharmaZac is one of the most dynamic pharmaceutical firms in Greece and an important player in manufacturing, exports and healthcare.

Research & Development

PharmaZac is investing more than 15% of its annual income on new products, technologies and infastructure.


We understand how a modern Pharmaceutical company should function. PharmaZac provides a full array of services from Sales, Marketing and Business Development to Distribution & Logistics.


PharmaZac offers a wide range of more than 90 products in the therapeutic areas of Cardiology, Oncology, CNS, Urology, Dermatology, Contrast Media, Antibiotics & Orthopaedics.

Latest News
  • Pharmazac launched the first Rosuvastatin generic in the Greek Pharmaceutical Market. Rosuvastatin is available in two forms of 14 and 30 film coated tablets and composition of 5mg, 10mg, 20mg and 40mg. Rosuvastain/Pharmazac is an HMG – CoA reductase inhibitor indicated for patients with primary hypercholesterolaemia......

  • Pharmazac has released the new product Nitastin 20mg film coated tablet for treatment of heart disease In addition to the hypolipidemic actions Nitastin has beneficial effects in endothelial dysfunction, on the vascular wall, the state of atheroma, improves blood rheology, have antioxidant, antiproliferative properties. There......

  • Pharmazac has released the new product Ractilen (rasagiline tabs 1mg/tab ) for the treatment of PD...

  • Pharmazac has released the new product Calcium Folinate,  an injectable solution 200mg/20ml Bt x 1 vial x20ml for intravenous or intramuscular use. Calcium Folinate / Pharmazac is the only available generic product in the Greek market....


Years of Research & Development


Business Units


European Awards


Global Certifications

Memberships & Awards

  • Pharmazac is a proud member of the Hellenic Pharmaceutical Industry Association with an active intervention in policy making and regulatory changes.
  • Pharmazac is regularly inspected by the Authorities and International Clients for its logistics, distribution and wholesale commercial best practices. In 2016 the company’s GDP has been renewed.
  • As a permanent member of the Generics Association Pharmazac has joined the working committees and is an active participant.
  • The implementation of Good Manufacturing Practice is certified by local and international authorities while a robust QA system suns through the company’s operations.
  • Pharmazac first received an ISO Certificate in 1997 and has been audited without interruption since then.


We are getting bigger
Are you interested in working in an awarded pharmaceutical company?